Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yin Qiao Jie Du Pian is a traditional Chinese medicine (TCM) formulation manufactured by Sichuan Senke Pharmaceutical (Senkeyuan). It is an approved product in China, recognized as a National Essential Drug and included in the National Medical Insurance catalog. The formulation is based on the classic Yin Qiao San formula, which has been used for centuries to treat the early stages of wind-heat type common cold and influenza. Its therapeutic actions are characterized in TCM as clearing heat, detoxifying the body, and relieving exterior symptoms through pungent and cool properties. It is typically indicated for symptoms such as fever, headache, cough, sore throat, and thirst. As a multi-herb formulation, it contains extracts from several plants, including *Lonicera japonica* and *Forsythia suspensa*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yin Qiao Jie Du Pian.